David A. Bergin

1.9k total citations
27 papers, 1.6k citations indexed

About

David A. Bergin is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Immunology. According to data from OpenAlex, David A. Bergin has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in David A. Bergin's work include Protease and Inhibitor Mechanisms (10 papers), Neonatal Respiratory Health Research (7 papers) and Cystic Fibrosis Research Advances (5 papers). David A. Bergin is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Neonatal Respiratory Health Research (7 papers) and Cystic Fibrosis Research Advances (5 papers). David A. Bergin collaborates with scholars based in Ireland, United Kingdom and Switzerland. David A. Bergin's co-authors include Emer P. Reeves, Noel G. McElvaney, Kevin Kavanagh, Martin Clynes, Killian Hurley, Frans B. Wientjes, J. A. A. Renwick, Oliver J. McElvaney, Marc Brennan and Joanne Keenan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

David A. Bergin

27 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Bergin Ireland	17	502	438	371	318	232	27	1.6k
Oliver Wiedow Germany	22	613 1.2×	243 0.6×	541 1.5×	380 1.2×	32 0.1×	37	1.9k
Jackie C. Timans France	9	1.6k 3.1×	108 0.2×	665 1.8×	259 0.8×	45 0.2×	10	2.2k
Sinéad M. Smith Ireland	26	679 1.4×	253 0.6×	604 1.6×	220 0.7×	15 0.1×	60	2.3k
Matt X. G. Shao United States	11	403 0.8×	435 1.0×	385 1.0×	109 0.3×	11 0.0×	11	1.3k
Matija Rijavec Slovenia	23	401 0.8×	128 0.3×	381 1.0×	165 0.5×	27 0.1×	73	1.4k
Caroline Junqueira Brazil	17	996 2.0×	283 0.6×	1.3k 3.5×	163 0.5×	31 0.1×	27	2.3k
Lisa Schopf United States	23	866 1.7×	91 0.2×	309 0.8×	151 0.5×	25 0.1×	32	2.1k
Borko Amulic Germany	17	1.6k 3.1×	161 0.4×	686 1.8×	86 0.3×	17 0.1×	27	2.4k
Leanne Peiser United Kingdom	12	805 1.6×	75 0.2×	376 1.0×	60 0.2×	31 0.1×	18	1.3k

Countries citing papers authored by David A. Bergin

Since Specialization

Citations

This map shows the geographic impact of David A. Bergin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Bergin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Bergin more than expected).

Fields of papers citing papers by David A. Bergin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Bergin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Bergin. The network helps show where David A. Bergin may publish in the future.

Co-authorship network of co-authors of David A. Bergin

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Bergin. A scholar is included among the top collaborators of David A. Bergin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Bergin. David A. Bergin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

White, Michelle M., Debananda Gogoi, David A. Bergin, et al.. (2022). Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease. American Journal of Respiratory Cell and Molecular Biology. 67(1). 76–88. 7 indexed citations

Hawkins, Padraig, Claudie Gabillard-Lefort, David A. Bergin, et al.. (2021). In vitroandin vivomodulation of NADPH oxidase activity and reactive oxygen species production in human neutrophils by α₁-antitrypsin. ERJ Open Research. 7(4). 234–2021. 6 indexed citations

Price, David, et al.. (2017). Asthma referrals: a key component of asthma management that needs to be addressed. Journal of Asthma and Allergy. Volume10. 209–223. 64 indexed citations

Bergin, David A., et al.. (2015). Activation of Neutrophils via IP3 Pathway Following Exposure to Demodex-Associated Bacterial Proteins. Inflammation. 39(1). 425–433. 24 indexed citations

Seheult, Jansen N., P. O’Connell, Imran Sulaiman, et al.. (2014). The Acoustic Features of Inhalation can be Used to Quantify Aerosol Delivery from a Diskus™ Dry Powder Inhaler. Pharmaceutical Research. 31(10). 2735–2747. 42 indexed citations

Hurley, Killian, Noreen Lacey, David A. Bergin, et al.. (2014). Alpha-1 Antitrypsin Augmentation Therapy Corrects Accelerated Neutrophil Apoptosis in Deficient Individuals. The Journal of Immunology. 193(8). 3978–3991. 51 indexed citations

Bergin, David A., et al.. (2014). The Circulating Proteinase Inhibitor α-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity. Science Translational Medicine. 6(217). 217ra1–217ra1. 133 indexed citations

McElvaney, Oliver J., Niamh O’Reilly, Michelle M. White, et al.. (2014). The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis. Molecular Immunology. 63(2). 550–558. 12 indexed citations

Bergin, David A., Oliver J. McElvaney, Cormac McCarthy, et al.. (2014). Galectin-9 Signaling through TIM-3 Is Involved in Neutrophil-Mediated Gram-Negative Bacterial Killing: An Effect Abrogated within the Cystic Fibrosis Lung. The Journal of Immunology. 192(5). 2418–2431. 40 indexed citations

10.

Pohl, Kerstin, Elaine Hayes, Joanne Keenan, et al.. (2014). A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. Blood. 124(7). 999–1009. 132 indexed citations

11.

Bergin, David A., Killian Hurley, Noel G. McElvaney, & Emer P. Reeves. (2012). Alpha-1 Antitrypsin: A Potent Anti-Inflammatory and Potential Novel Therapeutic Agent. Archivum Immunologiae et Therapiae Experimentalis. 60(2). 81–97. 112 indexed citations

12.

T, King, David A. Bergin, Etaoin Kent, et al.. (2012). Endothelial Progenitor Cells in Mothers of Low-Birthweight Infants: A Link between Defective Placental Vascularization and Increased Cardiovascular Risk?. The Journal of Clinical Endocrinology & Metabolism. 98(1). E33–E39. 14 indexed citations

13.

Reeves, Emer P., David A. Bergin, Elaine Hayes, et al.. (2011). A novel neutrophil derived inflammatory biomarker of pulmonary exacerbation in cystic fibrosis. Journal of Cystic Fibrosis. 11(2). 100–107. 11 indexed citations

14.

Bergin, David A., Emer P. Reeves, Elaine Hayes, et al.. (2011). Neutrophil Derived CD16B: Alpha-1 Antitrypsin Complex; A Novel Biomarker Of Inflammation In Cystic Fibrosis. A5739–A5739. 1 indexed citations

15.

Reeves, Emer P., David A. Bergin, Michelle Murray, & Noel G. McElvaney. (2011). The Involvement of Glycosaminoglycans in Airway Disease Associated with Cystic Fibrosis. The Scientific World JOURNAL. 11. 959–971. 22 indexed citations

16.

Bergin, David A., Emer P. Reeves, Paula Meleady, et al.. (2010). α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. Journal of Clinical Investigation. 120(12). 4236–4250. 224 indexed citations

17.

Reeves, Emer P., Michael Williamson, Barry J. Byrne, et al.. (2009). IL-8 Dictates Glycosaminoglycan Binding and Stability of IL-18 in Cystic Fibrosis. The Journal of Immunology. 184(3). 1642–1652. 39 indexed citations

18.

Bergin, David A., Catherine M. Greene, Erwin E. Sterchi, et al.. (2008). Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway. Journal of Biological Chemistry. 283(46). 31736–31744. 90 indexed citations

19.

Bergin, David A., Lisa Murphy, Joanne Keenan, Martin Clynes, & Kevin Kavanagh. (2006). Pre-exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial peptides. Microbes and Infection. 8(8). 2105–2112. 125 indexed citations

20.

Bergin, David A., Marc Brennan, & Kevin Kavanagh. (2003). Fluctuations in haemocyte density and microbial load may be used as indicators of fungal pathogenicity in larvae of Galleria mellonella. Microbes and Infection. 5(15). 1389–1395. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact